Obligatory 发表于 2025-3-23 10:45:34

Submitted on: 24 April 2018.
Revised on: 18 May 2018.
Accepted on: 29 June 2018.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

OATH 发表于 2025-3-23 17:17:16

Submitted on: 23 October 2001.
Revised on: 11 February 2002.
Accepted on: 25 February 2002.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

贸易 发表于 2025-3-23 21:46:03

http://reply.papertrans.cn/2/158/15711/15711-13.png

antidote 发表于 2025-3-23 23:59:35

http://reply.papertrans.cn/2/158/15711/15711-14.png

分开如此和谐 发表于 2025-3-24 02:25:27

http://reply.papertrans.cn/2/158/15711/15711-15.png

Genistein 发表于 2025-3-24 07:35:58

http://reply.papertrans.cn/2/158/15711/15711-16.png

SOW 发表于 2025-3-24 14:02:05

http://reply.papertrans.cn/2/158/15711/15711-17.png

Genome 发表于 2025-3-24 14:54:54

http://reply.papertrans.cn/2/158/15711/15711-18.png

细节 发表于 2025-3-24 20:19:02

http://reply.papertrans.cn/2/158/15711/15711-19.png

Dawdle 发表于 2025-3-25 01:09:16

http://reply.papertrans.cn/2/158/15711/15711-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:2.569 (J CARDIOVASC PHARM T) (1074-2484). (